Thomas Schall

Direktor/Vorstandsmitglied bei IMMUNEERING CORPORATION

Vermögen: 4 147 $ am 30.04.2024

64 Jahre

Health Technology

Consumer Services

Aktive Positionen von Thomas Schall

Unternehmen	Position	Beginn	Ende
IMMUNEERING CORPORATION	Direktor/Vorstandsmitglied	12.03.2024	-

Unternehmen	Position	Beginn	Ende
CHEMOCENTRYX, INC.	Direktor/Vorstandsmitglied	01.10.1997	01.04.2012
	Vorstandsvorsitzender	01.10.1997	20.10.2022
	Vorsitzender	01.04.2012	20.10.2022
	Gründer	01.10.1997	20.10.2022
	Präsident	01.10.1997	20.10.2022
DNAX Research, Inc.	Corporate Officer/Principal	01.12.1993	01.01.1997
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Technik-/Wissenschafts-/F&E-Leiter	-	-

Stanford University	Doctorate Degree
Northern Illinois University	Undergraduate Degree

International

Vereinigte Staaten

Operativ

Sektoral

Health Technology	4
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
IMMUNEERING CORPORATION	Health Technology

Private Unternehmen	3
ChemoCentryx, Inc. ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA.	Health Technology
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology
DNAX Research, Inc.